You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: October 5, 2024

CARBOPROST TROMETHAMINE Drug Patent Profile


✉ Email this page to a colleague

« Back to Dashboard


When do Carboprost Tromethamine patents expire, and when can generic versions of Carboprost Tromethamine launch?

Carboprost Tromethamine is a drug marketed by Alembic, Amneal, Ani Pharms, Caplin, Dr Reddys, Eugia Pharma, Gland Pharma Ltd, Long Grove Pharms, Micro Labs, Sola Pharms, Steriscience Speclts, and Sunny. and is included in twelve NDAs.

The generic ingredient in CARBOPROST TROMETHAMINE is carboprost tromethamine. There is one drug master file entry for this compound. Eighteen suppliers are listed for this compound. Additional details are available on the carboprost tromethamine profile page.

DrugPatentWatch® Litigation and Generic Entry Outlook for Carboprost Tromethamine

A generic version of CARBOPROST TROMETHAMINE was approved as carboprost tromethamine by DR REDDYS on July 2nd, 2019.

  Sign Up

AI Research Assistant
Questions you can ask:
  • What is the 5 year forecast for CARBOPROST TROMETHAMINE?
  • What are the global sales for CARBOPROST TROMETHAMINE?
  • What is Average Wholesale Price for CARBOPROST TROMETHAMINE?
Drug patent expirations by year for CARBOPROST TROMETHAMINE
Recent Clinical Trials for CARBOPROST TROMETHAMINE

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
Northwestern UniversityEarly Phase 1
C.R.Darnall Army Medical CenterN/A
American University of Beirut Medical CenterN/A

See all CARBOPROST TROMETHAMINE clinical trials

Pharmacology for CARBOPROST TROMETHAMINE
Medical Subject Heading (MeSH) Categories for CARBOPROST TROMETHAMINE
Anatomical Therapeutic Chemical (ATC) Classes for CARBOPROST TROMETHAMINE

US Patents and Regulatory Information for CARBOPROST TROMETHAMINE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Alembic CARBOPROST TROMETHAMINE carboprost tromethamine INJECTABLE;INJECTION 217198-001 Jun 15, 2023 AP RX No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Gland Pharma Ltd CARBOPROST TROMETHAMINE carboprost tromethamine INJECTABLE;INJECTION 217657-001 Aug 7, 2023 AP RX No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Caplin CARBOPROST TROMETHAMINE carboprost tromethamine INJECTABLE;INJECTION 216882-001 Feb 13, 2023 AP RX No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.